Broncus Holding Corporation

SEHK:2216 Stock Report

Market Cap: HK$316.3m

Broncus Holding Past Earnings Performance

Past criteria checks 0/6

Broncus Holding has been growing earnings at an average annual rate of 21.7%, while the Medical Equipment industry saw earnings growing at 14.7% annually. Revenues have been growing at an average rate of 5.6% per year.

Key information

21.7%

Earnings growth rate

34.3%

EPS growth rate

Medical Equipment Industry Growth13.7%
Revenue growth rate5.6%
Return on equity-12.0%
Net Margin-244.2%
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

We Think Broncus Holding (HKG:2216) Needs To Drive Business Growth Carefully

Mar 21
We Think Broncus Holding (HKG:2216) Needs To Drive Business Growth Carefully

Broncus Holding (HKG:2216) Is In A Good Position To Deliver On Growth Plans

Nov 30
Broncus Holding (HKG:2216) Is In A Good Position To Deliver On Growth Plans

Will Broncus Holding (HKG:2216) Spend Its Cash Wisely?

May 31
Will Broncus Holding (HKG:2216) Spend Its Cash Wisely?

Companies Like Broncus Holding (HKG:2216) Are In A Position To Invest In Growth

Feb 27
Companies Like Broncus Holding (HKG:2216) Are In A Position To Invest In Growth

An Intrinsic Calculation For Broncus Holding Corporation (HKG:2216) Suggests It's 47% Undervalued

Dec 06
An Intrinsic Calculation For Broncus Holding Corporation (HKG:2216) Suggests It's 47% Undervalued

Analysts Just Slashed Their Broncus Holding Corporation (HKG:2216) EPS Numbers

Sep 04
Analysts Just Slashed Their Broncus Holding Corporation (HKG:2216) EPS Numbers

Here's Why We're Not Too Worried About Broncus Holding's (HKG:2216) Cash Burn Situation

Jun 21
Here's Why We're Not Too Worried About Broncus Holding's (HKG:2216) Cash Burn Situation

Revenue & Expenses Breakdown

How Broncus Holding makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SEHK:2216 Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 249-211716
31 Mar 249-251818
31 Dec 2310-282020
30 Sep 2311-272120
30 Jun 2311-272220
31 Mar 2310-272120
31 Dec 229-282119
30 Sep 2210-1192419
30 Jun 2211-2092618
31 Mar 2211-2222917
31 Dec 2111-2363217
30 Sep 218-1562815
30 Jun 215-762413
31 Mar 214-621911
31 Dec 203-48149
31 Dec 198-321711

Quality Earnings: 2216 is currently unprofitable.

Growing Profit Margin: 2216 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 2216 is unprofitable, but has reduced losses over the past 5 years at a rate of 21.7% per year.

Accelerating Growth: Unable to compare 2216's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 2216 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-4.3%).


Return on Equity

High ROE: 2216 has a negative Return on Equity (-12.02%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/25 19:57
End of Day Share Price 2024/12/24 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Broncus Holding Corporation is covered by 7 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullCMB International Securities Limited
Yang HuangCredit Suisse
Jie Sheng LiuCredit Suisse